Advertorial
Top analysts agree

33 of Wall Street's top‑ranked analysts rate one stock a Buy. This week it fell to 9% below its high.

No stock on Stock Radar's list has more top-ranked analysts behind it. Here is what they see in it. The name stays locked.

  • Goldman Sachs
  • Morgan Stanley
  • JPMorgan
  • Bank of America
  • Citi
  • Deutsche Bank
  • Barclays
  • Evercore ISI
David | Senior Analyst @ Exent Research Desk5 min read

Top‑ranked analysts rating it Buy

Last 90 days, on Stock Radar's Strong Buy list of 200 stocks (Oct 17, 2026)

  • The locked stock (#1 on the list)33
  • Nvidia (#2)33
  • The average stock on the list13
#1 on Stock RadarMega-cap tech
33 of 37Buy ratings from top‑ranked analystsLast 90 days
BuyTheir rating, all 33No analyst rates it Sell
−9%Below its 52‑week highOct 16 close
+18%To their average targetFrom the Oct 16 close

Exent analyst data, Oct 17, 2026. Targets are analysts' opinions, not promises.

Wall Street analysts rarely agree. On most stocks they split between Buy, Hold and Sell. This one is different. In the last 90 days, 37 analysts rated it a Buy, and 33 of them are top-ranked in Exent's analyst data: 4 stars or more out of 5 for the track record of their calls.

Then the market turned. In three days this week the stock fell 7%, and it closed Friday 9% below its 52-week high. Here is who rates it, what they see in it, and what could go wrong.

It's not Nvidia. On Stock Radar's list, only Nvidia ties it.

Everyone expects the top analysts to love Nvidia. They do: 33 of them rate it a Buy. That is not news. The other stock with 33 is. It is a mega-cap tech company, and it sits at #1 on Stock Radar's Strong Buy list. The average stock on that list has 13 top-ranked analysts behind it.

In the week it fell, 12 of the 33 restated their Buy. No analyst downgraded it.

10 of the 33 Buy ratings

Each analyst's latest call. Analyst rank: where the analyst stands among the 5,000+ Wall Street analysts Exent ranks by the track record of their calls.

FirmRatingTargetAnalyst rankDate
Deutsche BankBuy$820 (+16%)Top 19%Oct 16
Bank of AmericaBuy$810 (+14%)Top 3%Oct 16
JPMorganBuyupgraded Sep 10$920 (+30%)Top 18%Oct 15
CitiBuy$895 (+26%)Top 31%Oct 15
UBSBuytarget raised$884 (+25%)Top 22%Oct 14
GuggenheimBuytarget raised$850 (+20%)Top 13%Oct 14
TruistBuytarget raised$1,000 (+41%)Top 15%Oct 13
Evercore ISIBuy$860 (+21%)Top 9%Oct 13
BernsteinBuy$800 (+13%)Top 11%Sep 28
BarclaysBuy$780 (+10%)Top 7%Jul 30
  • Deutsche Bank
    Rating
    Buy
    Target
    $820 (+16%)
    Analyst rank
    Top 19%
    Date
    Oct 16
  • Bank of America
    Rating
    Buy
    Target
    $810 (+14%)
    Analyst rank
    Top 3%
    Date
    Oct 16
  • JPMorgan
    Rating
    Buyupgraded Sep 10
    Target
    $920 (+30%)
    Analyst rank
    Top 18%
    Date
    Oct 15
  • Citi
    Rating
    Buy
    Target
    $895 (+26%)
    Analyst rank
    Top 31%
    Date
    Oct 15
  • UBS
    Rating
    Buytarget raised
    Target
    $884 (+25%)
    Analyst rank
    Top 22%
    Date
    Oct 14
  • Guggenheim
    Rating
    Buytarget raised
    Target
    $850 (+20%)
    Analyst rank
    Top 13%
    Date
    Oct 14
  • Truist
    Rating
    Buytarget raised
    Target
    $1,000 (+41%)
    Analyst rank
    Top 15%
    Date
    Oct 13
  • Evercore ISI
    Rating
    Buy
    Target
    $860 (+21%)
    Analyst rank
    Top 9%
    Date
    Oct 13
  • Bernstein
    Rating
    Buy
    Target
    $800 (+13%)
    Analyst rank
    Top 11%
    Date
    Sep 28
  • Barclays
    Rating
    Buy
    Target
    $780 (+10%)
    Analyst rank
    Top 7%
    Date
    Jul 30
Deutsche BankBuy · Top 19% analyst · Oct 16
$820 (+16%)
Bank of AmericaBuy · Top 3% analyst · Oct 16
$810 (+14%)
JPMorganBuy · Top 18% analyst · Oct 15
$920 (+30%)
CitiBuy · Top 31% analyst · Oct 15
$895 (+26%)
UBSBuy · Top 22% analyst · Oct 14
$884 (+25%)
GuggenheimBuy · Top 13% analyst · Oct 14
$850 (+20%)
TruistBuy · Top 15% analyst · Oct 13
$1,000 (+41%)
Evercore ISIBuy · Top 9% analyst · Oct 13
$860 (+21%)
BernsteinBuy · Top 11% analyst · Sep 28
$800 (+13%)
BarclaysBuy · Top 7% analyst · Jul 30
$780 (+10%)

Upside measured from the Oct 16, 2026 close. Targets are analysts' opinions, not promises.

How every analyst rates it

The 43 analysts who rated it in the last 90 days

  • Buy37
  • Hold6
  • Sell0

33 of the 37 Buy ratings come from top-ranked analysts. 3 top-ranked analysts rate it Hold.

Where the targets sit

Against the Oct 16, 2026 close

Highest (Truist, Buy)
$1,000 (+41%)
Average of the top-ranked 33
+18%
Lowest (BMO Capital, Hold)
$580 (−18%)

Average of the 31 top-ranked analysts who gave a target.

Between Monday and Friday, 12 of the 33 top-ranked analysts restated their rating, and every one kept its Buy. In the last 90 days, not one of the 43 analysts who rate it downgraded it. JPMorgan went the other way: it upgraded the stock from Neutral on September 10, and its target now sits 30% above Friday's close.

Why 33 top‑ranked analysts agree, in plain words.

+28%Sales growth, last quarterQuarter to Jun 30, vs a year earlier

The business is still growing fast for a company its size. Bank of America expects its next results, due next week, to beat Wall Street's sales estimate, helped by AI.

17 of 33Raised their targets since JulySince its last results, Jul 29

It released new AI models this week. Guggenheim says its AI is closing the gap with the leading AI labs. Guggenheim and UBS both raised their targets, pointing to new ways the AI could make money.

+18%To their average targetFrom the Oct 16 close

The price fell. The targets did not. The top-ranked analysts' average target sits 18% above Friday's close, and Truist's new target of $1,000, set on Oct 13, sits 41% above it.

What could go wrong. The case against, in numbers.

AI is costing it a lot

Its last results, the quarter to Jun 30, 2026, against the same quarter a year earlier

−8%Operating profitWhile sales grew 28%
+82%Capital spendingServers and data centres
−81%Free cash flowCash left after that spending
−14%Profit per share vs estimateIt missed, Jul 29
6Analysts say Hold3 of them top-ranked
−27%Its 52‑week lowMar 27, vs Friday's close

Not everyone agrees. The lowest target, a Hold from BMO Capital, sits 18% below Friday's close. Three Buy ratings carry targets, set in July, that are below Friday's close too. On Oct 14 Goldman Sachs kept its Buy but lowered its target, citing rising costs.

The company reports results next week, and one report can move a stock sharply either way. It has fallen before: in March it traded 27% below Friday's price. A Buy from 33 analysts is an opinion, not a promise.

Before you go looking for it.

Haven't I already missed it?

It closed Friday 9% below its September high.

The top-ranked analysts' average target is 18% above that close.

Is this a recommendation?

No. It is research: what the best-ranked analysts are doing, and what could go wrong.

You decide what fits your money.

See the stock in Stock Radar today.

Gems: Stock Radar's Strong Buy list, built from the ratings of Wall Street's best-ranked analysts and refreshed daily.

What you get

  • The stock in this article, named, with all 33 top-ranked analysts behind it
  • Every rating, target and analyst track record, side by side
  • Top Strong Buy picks, ranked and refreshed daily
  • Early flags with entry and exit levels
  • Where company insiders are buying

Unlock the name

See the stock, every rating behind it and the rest of the list.

Stock
Rank on Stock Radar
#1
Top-ranked analysts, Buy
33 of 37
To their average target
+18%
Reveal the stock

Price and plan details are on the next page before you pay anything.

Sources

  • Exent analyst data: ratings, price targets and analyst rankings (as of Oct 17, 2026)
  • Stock Radar's Strong Buy list (Oct 17, 2026)
  • Daily prices, Oct 16, 2025 to Oct 16, 2026
  • Company results for the quarter to Jun 30, 2026 (reported Jul 29, 2026) and the same quarter a year earlier
  • Analyst notes as reported by Proactive Investors (Oct 14 and 16, 2026), Benzinga (Oct 14 and 16, 2026) and Invezz (Oct 14, 2026)
  • Results date: Investopedia and Benzinga (Oct 16, 2026)

Advertorial, presented by Exent. For information and education only; not investment advice or a recommendation to buy or sell any security. Prices, ratings and targets are as of the dates shown and change daily. Analyst ratings and targets are third-party opinions, not guarantees. "Top-ranked" means rated 4 stars or more out of 5 in Exent's ranking of Wall Street analysts by the track record of their calls. Investing involves risk, including the possible loss of principal. Exent AI is an informational research platform and is not an investment adviser, broker-dealer or fiduciary.